We are live on ! Find out more
SEI Investments

SEI Investments Portfolio holdings

AUM $108B
1-Year Est. Return 26.14%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+26.14%
3 Year Est. Return
+80.41%
5 Year Est. Return
+95.44%
10 Year Est. Return
+382.16%
AUM
$45B
AUM Growth
+$170M
Cap. Flow
-$2.88B
Cap. Flow %
-6.41%
Top 10 Hldgs %
16.72%
Holding
2,757
New
109
Increased
859
Reduced
1,347
Closed
244

Sector Composition

Rank Sector Weight
1 Technology 15.76%
2 Healthcare 11.58%
3 Financials 10.07%
4 Consumer Discretionary 7.69%
5 Industrials 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
101
Home Depot
HD
$337B
$80.2M 0.18%
253,887
+11,243
+5% +$3.42M
AVGO icon
102
Broadcom
AVGO
$1.79T
$79.2M 0.18%
1,417,090
-12,460
-0.9% -$625K
MDT icon
103
Medtronic
MDT
$111B
$79.1M 0.18%
1,018,140
-120,486
-11% -$9.77M
RYAAY icon
104
Ryanair
RYAAY
$30B
$78.8M 0.18%
2,636,205
+117,210
+5% +$3.33M
WFC icon
105
Wells Fargo
WFC
$254B
$78.6M 0.17%
1,904,179
-214,805
-10% -$9.51M
TECH icon
106
Bio-Techne
TECH
$11.2B
$78.2M 0.17%
943,691
-125,357
-12% -$9.96M
XOM icon
107
ExxonMobil
XOM
$649B
$78.1M 0.17%
707,914
-51,922
-7% -$5.56M
ANET icon
108
Arista Networks
ANET
$200B
$77.6M 0.17%
2,557,164
-976,768
-28% -$30.1M
ABT icon
109
Abbott
ABT
$188B
$76.8M 0.17%
699,768
-95,288
-12% -$9.87M
MPWR icon
110
Monolithic Power Systems
MPWR
$62.4B
$76.7M 0.17%
216,961
+12,153
+6% +$4.37M
HOLX
111
DELISTED
Hologic
HOLX
$74.5M 0.17%
996,025
-89,555
-8% -$6.38M
DOC icon
112
Healthpeak Properties
DOC
$15.5B
$74.1M 0.16%
2,956,116
+320,957
+12% +$7.8M
A icon
113
Agilent Technologies
A
$39.5B
$73.8M 0.16%
493,294
+8,123
+2% +$1.16M
ABBV icon
114
AbbVie
ABBV
$466B
$73.7M 0.16%
455,842
-22,070
-5% -$3.38M
CCI icon
115
Crown Castle
CCI
$34.3B
$73.6M 0.16%
542,394
+9,188
+2% +$1.24M
ANSS
116
DELISTED
Ansys
ANSS
$72M 0.16%
297,929
+27,174
+10% +$6.33M
GILD icon
117
Gilead Sciences
GILD
$165B
$70.6M 0.16%
822,660
+131,753
+19% +$10.4M
LRCX icon
118
Lam Research
LRCX
$321B
$70.6M 0.16%
1,678,800
+916,910
+120% +$38.4M
TDY icon
119
Teledyne Technologies
TDY
$29.2B
$69.9M 0.16%
174,667
-48,012
-22% -$18.7M
PEP icon
120
PepsiCo
PEP
$195B
$69.8M 0.16%
386,521
+4,390
+1% +$783K
HON icon
121
Honeywell
HON
$76.4B
$69.3M 0.15%
343,342
-82,639
-19% -$15.8M
IDXX icon
122
Idexx Laboratories
IDXX
$44.9B
$68.7M 0.15%
168,386
+25,970
+18% +$10.1M
UPS icon
123
United Parcel Service
UPS
$89B
$67.7M 0.15%
389,251
-48,699
-11% -$8.43M
FISV
124
Fiserv Inc
FISV
$29.8B
$67.5M 0.15%
667,611
-200,207
-23% -$19.9M
RGA icon
125
Reinsurance Group of America
RGA
$15.6B
$66.8M 0.15%
469,936
-6,446
-1% -$900K

Similar funds

SEI Investments's Q4 2022 Portfolio in Review

As of Q4 2022, SEI Investments held 2,757 positions worth $45B, up 0.38% from $44.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

SEI Investments withdrew a net $2.88B in Q4 2022, closing 244 positions and reducing 1,347 holdings. Its most notable exit was Abiomed Inc, an estimated $63.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, SEI Investments opened a new position in iShares Core MSCI International Developed Markets ETF worth $219M.

  • SEI Investments's largest Q4 2022 buy was iShares Core MSCI International Developed Markets ETF: 3,906,565 shares worth $219M.
  • SEI Investments added most to Vanguard Emerging Markets Government Bond ETF in Q4 2022, an estimated $222M increase.
  • SEI Investments's biggest Q4 2022 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $223M.
  • SEI Investments fully exited Abiomed Inc in Q4 2022, selling an estimated $63.5M.
  • SEI Investments's ten largest holdings make up 17% of its $45B portfolio in Q4 2022.
  • SEI Investments opened 109 new positions and closed 244 in Q4 2022.
  • SEI Investments's portfolio value rose 0.38% quarter-over-quarter to $45B.

Based on SEI Investments's 13F filing for Q4 2022, filed 10 Feb 2023.